Committee criticises penalty limitations of its “curious” regulations
The Statutory Committee has decided to take no further action in the
case of a pharmacist who made a dispensing error after insisting that
Temgesic (buprenorphine) and fentanyl were the same medication. The
patient concerned had become ill after taking the Temgesic supplied
on a prescription for fentanyl.
The committee criticised the fact that it was unable to impose any penalty
if it did not consider a pharmacist’s conduct was such as to render
him unfit to be on the register.
At its meeting on 26 January, the committee inquired into the case of
Clive Ivor Hodgson, of 55 Hemingford Gardens, Leven Park, Yarm, Cleveland.
A complaint had been received from the Council of the Royal Pharmaceutical
Society alleging that Mr Hodgson, while pharmacist in charge of Sunningdale
Pharmacy, Sunningdale Drive, Eaglescliff, Stockton-on-Tees, had dispensed
12 Temgesic 0.2mg tablets against a prescription calling for six fentanyl
lozenges. He had advised the patient before the medicines were dispensed
that Temgesic tablets were the same medication as fentanyl lozenges.
Subsequently, he had also given that advice to the patient’s mother.
Geoff Hudson, of Penningtons (solicitors), appeared for the Council to
present the facts of the case.
Mr Hodgson, who attended the inquiry, was represented by Sara Morgan,
of Brooke North (solicitors).
The committee heard that on 31 March 2003, a patient suffering from acute
pancreatitis presented a prescription at the pharmacy which called for
six fentanyl 400mg lozenges. Mr Hodgson had explained that he had not
got fentanyl 400mg in stock and suggested she could be given twice the
amount of fentanyl 200mg instead.
However, he then told the patient he did not have fentanyl 200mg in stock
either and said he could give her Temgesic (buprenorphine) 0.2mg, which,
he said, was “the same medication”. The patient asked him
to confirm this, which he did, and told her Temgesic should be taken
in the same way as fentanyl lozenges. He then dispensed 12 Temgesic 0.2mg
tablets, labelled “two to be taken as directed”.
The patient did not take any Temgesic until 8 April, when she wakened
at 3am, took a dose, and slept until 6am. She awoke shaking, sweating,
feeling faint and vomiting and felt unwell until about 5pm.
During that day her mother had contacted the patient’s doctor and
been told that Temgesic and fentanyl were different medicines. When she
telephoned Mr Hodgson to query this, however, he had said they were the
same, being different brands of the same drug. On being told the doctor
had said they were different, he said he would find the prescription
and phone her back.
When he telephoned, Mr Hodgson admitted he had made an error and apologised.
Giving the committee’s decision, the chairman (Lord Fraser of Carmyllie,
QC), said that a deliberate error had been admitted by Mr Hodgson. It
had not, however, been an error made in circumstances from which he would
have derived any possible gain. Over a lifetime, Mr Hodgson had been
an exemplary pharmacist; that had been confirmed by the fine references
provided for him. After the event, he acted impeccably in apologising
and taking steps to assist the patient as best he could.
The committee did not consider it was an error such as would render him
unfit to be on the register. As that was the case, the committee had
no option other than to take no further action against Mr Hodgson.
The chairman commented that the committee was not happy about the “curious “ way
its regulations were framed. If it could not conclude that an error was
one such as would render a pharmacist unfit to be on the register, that
constituted a “hurdle” preventing it from taking a less severe
course.
Lord Fraser continued: “Unless we surmount that hurdle, we do not
even have the opportunity to reprimand or admonish a pharmacist. I have
come to the very clear view, supported by the committee, that we shall
ensure that if that hurdle is to be surmounted, we have a sound base
on which to do it.”
The chairman indicated that he would set out the committee’s reasons
for its decision at a future date.
Returning to the matter at the committee’s meeting on 19 July,
Lord Fraser said that, on reflection, the case raised no point of principle
and no further elaboration of the earlier decision was required.
Back to Top
|